1. Home
  2. MTEK vs TSBX Comparison

MTEK vs TSBX Comparison

Compare MTEK & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEK
  • TSBX
  • Stock Information
  • Founded
  • MTEK 2008
  • TSBX 2015
  • Country
  • MTEK Israel
  • TSBX United States
  • Employees
  • MTEK N/A
  • TSBX N/A
  • Industry
  • MTEK
  • TSBX
  • Sector
  • MTEK
  • TSBX
  • Exchange
  • MTEK Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • MTEK 14.7M
  • TSBX 11.8M
  • IPO Year
  • MTEK 2022
  • TSBX 2023
  • Fundamental
  • Price
  • MTEK $1.90
  • TSBX $0.45
  • Analyst Decision
  • MTEK
  • TSBX Strong Buy
  • Analyst Count
  • MTEK 0
  • TSBX 2
  • Target Price
  • MTEK N/A
  • TSBX $6.88
  • AVG Volume (30 Days)
  • MTEK 21.5K
  • TSBX 145.4K
  • Earning Date
  • MTEK 10-15-2024
  • TSBX 11-07-2024
  • Dividend Yield
  • MTEK N/A
  • TSBX N/A
  • EPS Growth
  • MTEK N/A
  • TSBX N/A
  • EPS
  • MTEK N/A
  • TSBX N/A
  • Revenue
  • MTEK $6,967,508.00
  • TSBX N/A
  • Revenue This Year
  • MTEK N/A
  • TSBX N/A
  • Revenue Next Year
  • MTEK N/A
  • TSBX N/A
  • P/E Ratio
  • MTEK N/A
  • TSBX N/A
  • Revenue Growth
  • MTEK 246.50
  • TSBX N/A
  • 52 Week Low
  • MTEK $0.94
  • TSBX $0.45
  • 52 Week High
  • MTEK $2.07
  • TSBX $5.75
  • Technical
  • Relative Strength Index (RSI)
  • MTEK 58.16
  • TSBX 16.75
  • Support Level
  • MTEK $1.80
  • TSBX $0.58
  • Resistance Level
  • MTEK $2.06
  • TSBX $0.70
  • Average True Range (ATR)
  • MTEK 0.09
  • TSBX 0.05
  • MACD
  • MTEK 0.02
  • TSBX 0.03
  • Stochastic Oscillator
  • MTEK 62.70
  • TSBX 1.10

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: